Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Fatty's Donut Shop -- Ignore unavailable to you. Want to Upgrade?

To: Matt Brown who wrote (2772)	8/3/1999 12:23:00 AM
From: Cytotekk	Read Replies (1) \| Respond to of 5041

FM-must be fate! 10:00 AM tomorrow I will be listening to the conference call of my namesake, CYTO. PSA immunohistochemistry and serological chemistry I know well...PSMA?...I don't know the medical necessity or advantages of PSMA at this time but I am interested in finding out the advantages of PSMA over PSA....I am in the business of anatomic pathology...the study of cells and tissues. CYTO's other products may also be very effective. I have yet to read the clinical studies of these products and I am no oncologist, but, the effective treatment of common cancers and/or their symptoms can be a very lucrative business. Cytotekk in Orlando.